论文部分内容阅读
The purpose of this study was to evaluate the perioperative complications in fetoscopy-guided laser therapy in feto-fetal transfusion syndrome. Study design: Details of feto-fetal transfusion syndrome cases who were delivered between 1999 and 2004 in a single center were reviewed retrospectively. Results: One hundred seventy-five procedures were performed percutaneously with the use of local anesthesia. Survival at 6 months of at least 1, 1, and 2 babies was 73% , 38% , and 35% , respectively. Placental abruption and miscarriage was diagnosed in 3 and 12 cases, respectively. Premature rupture of membranes occurred in 49 cases (28% ) and including 12, 29, and 46 cases that occurred before 24, 28, and 34 weeks of gestation, respectively. The entry of the trocar was transpla- cental in 48 cases (27% ), but it was not associated with miscarriage (P = .26), premature rupture of membranes (P = .58), or placental abruption (P = .37). Conclusion: Fetoscopic laser treatment of feto-fetal transfusion syndrome can be performed percutaneously with local anesthesia without significant maternal morbidity. Transplacental entry was not associated with premature rupture of membranes or miscarriage.
The purpose of this study was to evaluate the perioperative complications in fetoscopy-guided laser therapy in feto-fetal transfusion syndrome. Study design: Details of feto-fetal transfusion syndrome cases who were delivered between 1999 and 2004 in a single center were reviewed retrospectively. Results: One hundred seventy-five procedures were performed percutaneously with the use of local anesthesia. Survival at 6 months of at least 1, 1, and 2 babies was 73%, 38%, and 35%, respectively. Placental abruption and miscarriage was diagnosed in 3 and 12 cases, respectively. Premature rupture of the patients occurred in 49 cases (28%) and including 12, 29, and 46 cases that occurred before 24, 28, and 34 weeks of gestation, respectively. The entry of the trocar was transpla- cental in 48 cases (27%), but it was not associated with miscarriage (P = .26), premature rupture of membranes (P = .58), or placental abruption (P = .37) laser treatment of feto-fetal transf usion syndrome can be performed percutaneously with local anesthesia without significant maternal morbidity. Transplacental entry was not associated with premature rupture of membranes or miscarriage.